Key Metrics
CiteScore 

2.7
H-Index 

62
Impact Factor 

< 5
SJR 

Q3Drug Discovery

SNIP 

0.56
Recommended pre-submission checks
Powered by 

Topics Covered on Assay and Drug Development Technologies
Assay and Drug Development Technologies Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
SJR
| Overview | |
| Publisher | MARY ANN LIEBERT, INC |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 2002 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Assay and Drug Development Technologies ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Assay and Drug Development Technologies
Integrated In Vivo and In Silico Approaches for Targeting JAK2/STAT3/SOCS3: Repurposing Boeravinone B and Resveratrol as Chemopreventive Agents in Colon Cancer.
- 23 Jul 2026
- Assay and drug development technologies
Indolizine Compound Selection for HPV Anticancer Active Prediction Using CNN Classifier with ADME Descriptors.
- 1 Jul 2026
- Assay and drug development technologies
Molecular Mechanisms and Optimization Strategies for the Impact of Antihypertensive, Lipid-Lowering, and Antidiabetic Drugs on Gut Microbiota.
- 25 Jun 2026
- Assay and drug development technologies
Identification of Broad-Spectrum Inhibitors Targeting Multiple Amyloidogenic Proteins Using Functional Group-Based Virtual Screening.
- 23 Jun 2026
- Assay and drug development technologies
Formulation, Characterization, and Biological Assessment of Embelin-Loaded Glycerosomes.
- 16 Jun 2026
- Assay and drug development technologies
Molecular Mechanism of μ-Opioid Receptor Activation.
- 18 Apr 2026
- Assay and drug development technologies
Integrated In Vivo and In Silico Approaches for Targeting JAK2/STAT3/SOCS3: Repurposing Boeravinone B and Resveratrol as Chemopreventive Agents in Colon Cancer.
- 23 Jul 2026
- Assay and drug development technologies
Indolizine Compound Selection for HPV Anticancer Active Prediction Using CNN Classifier with ADME Descriptors.
- 1 Jul 2026
- Assay and drug development technologies
Molecular Mechanisms and Optimization Strategies for the Impact of Antihypertensive, Lipid-Lowering, and Antidiabetic Drugs on Gut Microbiota.
- 25 Jun 2026
- Assay and drug development technologies
Identification of Broad-Spectrum Inhibitors Targeting Multiple Amyloidogenic Proteins Using Functional Group-Based Virtual Screening.
- 23 Jun 2026
- Assay and drug development technologies
Formulation, Characterization, and Biological Assessment of Embelin-Loaded Glycerosomes.
- 16 Jun 2026
- Assay and drug development technologies
Molecular Mechanism of μ-Opioid Receptor Activation.
- 18 Apr 2026
- Assay and drug development technologies